PubMed

Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme.

Loutfy M, Ribera E, Florence E, De Wit S, Castagna A, Ryan R, Hill A, Vanaken H, van Delft Y, Marks S.

J Antimicrob Chemother. 2009 Dec;64(6):1341-4. Epub 2009 Oct 14. No abstract available. PMID: 19828488 [PubMed - in process]Related articles

The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patients.

Suarez-Lozano I, Viciana P, Lacalle JR, Teira R, Lozano F, Lopez-Aldeguer J, Pedrol E, Domingo P, Cosin J, Roca B, Geijo P, Fuente B, Vergara A, Ribera E, Galindo MJ, Zapata A, Sanchez T, Vidal F, Munoz-Sanz A, Munoz-Sanchez J, Garrido M.

HIV Med. 2009 Oct;10(9):573-9.PMID: 19785666 [PubMed - in process]Related articles

Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection.

Imaz A, del Saz SV, Ribas MA, Curran A, Caballero E, Falcó V, Crespo M, Ocaña I, Diaz M, de Gopegui ER, Riera M, Ribera E.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):382-6.PMID: 19654552 [PubMed - indexed for MEDLINE]Related articles

Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy.

Domingo P, Suarez-Lozano I, Torres F, Pomar V, Ribera E, Galindo MJ, Cosin J, Garcia-Alcalde ML, Vidal F, Lopez-Aldeguer J, Roca B, Gonzalez J, Lozano F, Garrido M; VACH Cohort Study Group.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):582-7.PMID: 19512939 [PubMed - indexed for MEDLINE]Related articles

How much fat loss is needed for lipoatrophy to become clinically evident?

Podzamczer D, Ferrer E, Martínez E, Del Rio L, Rosales J, Curto J, Ribera E, Barrufet P, Llibre JM, Aranda M; ABCDE Study Team.

AIDS Res Hum Retroviruses. 2009 Jun;25(6):563-7.PMID: 19500014 [PubMed - indexed for MEDLINE]Related articles

Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease.

Imaz A, Falcó V, Peñaranda M, Jordano Q, Martínez X, Nadal C, Curran A, Planes AM, Dalmau D, Ribera E, Riera M, Ruiz de Gopegui E, Pahissa A.

HIV Med. 2009 Jul;10(6):356-63. Epub 2009 Mar 11.PMID: 19490180 [PubMed - in process]Related articles

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

Martínez E, Arranz JA, Podzamczer D, Loncá M, Sanz J, Barragán P, Ribera E, Knobel H, Roca V, Gutiérrez F, Blanco JL, Mallolas J, Llibre JM, Clotet B, Dalmau D, Segura F, Arribas JR, Cosín J, Barrufet P, Casas E, Ferrer E, Curran A, González A, Pich J, Cruceta A, Arnaiz JA, Miró JM, Gatell JM; BICOMBO Study Team.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):290-7.PMID: 19398921 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.

Mallolas J, Podzamczer D, Milinkovic A, Domingo P, Clotet B, Ribera E, Gutiérrez F, Knobel H, Cosin J, Ferrer E, Arranz JA, Roca V, Vidal F, Murillas J, Pich J, Pedrol E, Llibre JM, Dalmau D, García I, Aranda M, Cruceta A, Martínez E, Blanco JL, Lazzari E, Gatell JM; ATAZIP Study Group.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):29-36.PMID: 19390327 [PubMed - indexed for MEDLINE]Related articles

Proinflammatory cytokine changes in clinically stable, virologically suppressed, HIV-infected patients switching from protease inhibitors to abacavir.

Virgili N, Fisac C, Martínez E, Ribera E, Gatell JM, Podzamczer D.

J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):552-3. No abstract available. PMID: 19300101 [PubMed - indexed for MEDLINE]Related articles

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis.

Moltó J, Llibre JM, Ribera E, Mínguez C, del Río JS, Pedrol E, Vallecillo G, Cedeño S, Valle M, Miranda C, Negredo E, Clotet B; SQV-HEP Study Group.

J Antimicrob Chemother. 2009 May;63(5):992-7. Epub 2009 Mar 11.PMID: 19279052 [PubMed - indexed for MEDLINE]Related articles

Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.

Van den Eynde E, Crespo M, Esteban JI, Jardi R, Ribera E, Carbonell J, Rodríguez-Frias F, Falco V, Curran A, Imaz A, Villar del Saz S, Ocaña I, Esteban R, Pahissa A.

Clin Infect Dis. 2009 Apr 15;48(8):1152-9. Erratum in: Clin Infect Dis. 2009 Aug 1;49(3):489. PMID: 19275492 [PubMed - indexed for MEDLINE]Related articles

Non-tuberculous mycobacteria in the sputum of HIV-infected patients: infection or colonization?

Alvarez-Uria G, Falcó V, Martín-Casabona N, Crespo M, Villar Del Saz S, Curran A, Ocaña I, Ribera E, Pahissa A.

Int J STD AIDS. 2009 Mar;20(3):193-5.PMID: 19255269 [PubMed - indexed for MEDLINE]Related articles

Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study).

Ribera E, Paradiñeiro JC, Curran A, Sauleda S, García-Arumí E, Castella E, Puiggròs C, Crespo M, Feijoo M, Diaz M, Del Saz SV, Planas M, Sureda D, Falcó V, Ocaña I, Pahissa A.

HIV Clin Trials. 2008 Nov-Dec;9(6):407-17.PMID: 19203906 [PubMed - indexed for MEDLINE]Related articles

Pulmonary valve implantation with the new Shelhigh Injectable Stented Pulmonic Valve.

Marianeschi SM, Santoro F, Ribera E, Catena E, Vignati G, Ghiselli S, Pedretti S, Suleyman O, Ustunsoy H, Berdat PA.

Ann Thorac Surg. 2008 Nov;86(5):1466-71; discussion 1472.PMID: 19049732 [PubMed - indexed for MEDLINE]Related articles

Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up.

Villar Del Saz S, Sued O, Falco V, Aguero F, Crespo M, Pumarola T, Curran A, Gatell J, Pahissa A, Miro J, Ribera E.

J Neurovirol. 2008 Nov 26:1-6. [Epub ahead of print]PMID: 19037815 [PubMed - as supplied by publisher]Related articles

Visceral leishmaniasis among liver transplant recipients: an overview.

Campos-Varela I, Len O, Castells L, Tallada N, Ribera E, Dopazo C, Vargas V, Gavaldà J, Charco R.

Liver Transpl. 2008 Dec;14(12):1816-9. Review. No abstract available. PMID: 19025932 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

Crespo M, Ribera E, Suárez-Lozano I, Domingo P, Pedrol E, López-Aldeguer J, Muñoz A, Viladés C, Sánchez T, Viciana P, Teira R, García-Alcalde ML, Vergara A, Lozano F, Galindo MJ, Cosin J, Roca B, Terrón A, Geijo P, Vidal F, Garrido M; VACH Cohort Study Group.

J Antimicrob Chemother. 2009 Jan;63(1):189-96. Epub 2008 Nov 6.PMID: 18988678 [PubMed - indexed for MEDLINE]Related articles

Recently acquired HIV infection in Spain (2003-2005): introduction of the serological testing algorithm for recent HIV seroconversion.

Romero A, González V, Granell M, Matas L, Esteve A, Martró E, Rodrigo I, Pumarola T, Miró JM, Casanova A, Ferrer E, Tural C, del Romero J, Rodríguez C, Caballero E, Ribera E, Casabona J; Standardized Algorithm for Recent HIV Infections (AERIVIH) study group.

Sex Transm Infect. 2009 Apr;85(2):106-10. Epub 2008 Nov 5.PMID: 18987013 [PubMed - indexed for MEDLINE]Related articles

Double-boosted protease inhibitor antiretroviral regimens: what role?

Ribera E, Curran A.

Drugs. 2008;68(16):2257-67. doi: 10.2165/0003495-200868160-00001. Review.PMID: 18973392 [PubMed - indexed for MEDLINE]Related articles

Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.

Berenguer J, González J, Ribera E, Domingo P, Santos J, Miralles P, Angels Ribas M, Asensi V, Gimeno JL, Pérez-Molina JA, Terrón JA, Santamaría JM, Pedrol E; GESIDA 3903 Team.

Clin Infect Dis. 2008 Oct 15;47(8):1083-92. Erratum in: Clin Infect Dis. 2008 Dec 15;47(12):1611. PMID: 18781872 [PubMed - indexed for MEDLINE]Related articles

Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome.

Curran A, Falcó V, Crespo M, Martinez X, Ribera E, Villar del Saz S, Imaz A, Coma E, Ferrer A, Pahissa A.

HIV Med. 2008 Oct;9(8):609-15. Epub 2008 Jun 28.PMID: 18557951 [PubMed - indexed for MEDLINE]Related articles

Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.

Alvarez-Martínez MJ, Moreno A, Miró JM, Valls ME, Rivas PV, de Lazzari E, Sued O, Benito N, Domingo P, Ribera E, Santín M, Sirera G, Segura F, Vidal F, Rodríguez F, Riera M, Cordero ME, Arribas JR, Jiménez de Anta MT, Gatell JM, Wilson PE, Meshnick SR; Spanish PCP Working Group.

Diagn Microbiol Infect Dis. 2008 Sep;62(1):34-43. Epub 2008 Jun 12.PMID: 18554841 [PubMed - indexed for MEDLINE]Related articles

Leishmania infantum DNA detection in urine from patients with visceral leishmaniasis and after treatment control.

Fisa R, Riera C, López-Chejade P, Molina I, Gállego M, Falcó V, Ribera E, Portús M.

Am J Trop Med Hyg. 2008 May;78(5):741-4.PMID: 18458307 [PubMed - indexed for MEDLINE]Related articlesFree article

[Longitudinal study on adherence, treatment satisfaction, and effectiveness of once-daily versus twice-daily antiretroviral therapy in a Spanish cohort of HIV-infected patients (CUVA study)]

Viciana P, Rubio R, Ribera E, Knobel H, Iribarren JA, Arribas JR, Pérez-Molina JA; Investigadores del Estudio CUVA.

Enferm Infecc Microbiol Clin. 2008 Mar;26(3):127-34. Spanish. PMID: 18358210 [PubMed - indexed for MEDLINE]Related articlesFree article

First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort.

Domingo P, Suárez-Lozano I, Torres F, Teira R, Lopez-Aldeguer J, Vidal F, Muñoz A, Viciana P, Lozano F, Vergara A, Roca B, García Alcalde ML, Cosín J, Terrón A, Galindo MJ, Geijo P, Ribera E, Gonzalez J, Sanchez T, Lacalle JR, Garrido M.

J Antimicrob Chemother. 2008 Jun;61(6):1348-58. Epub 2008 Mar 20.PMID: 18356150 [PubMed - indexed for MEDLINE]Related articlesFree article

Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients.

Crespo M, Pou L, Esteban JI, Falcó V, Ribera E, Lopez R, Sauleda S, Curran A, Villar del Saz S, Feijoo M, Ocaña I, Pahissa A.

Antivir Ther. 2007;12(8):1217-23.PMID: 18240861 [PubMed - indexed for MEDLINE]Related articles

Efficacy of recombinant interleukin-2 (rIL-2) in patients with advanced HIV-1 infection and blunted immune response to HAART.

Crespo M, Caragol I, Falcó V, Ribera E, Urban S, Pahissa A.

Enferm Infecc Microbiol Clin. 2008 Jan;26(1):27-31.PMID: 18208763 [PubMed - indexed for MEDLINE]Related articlesFree article

[Efficacy and safety of a reduced-dose of stavudine in HIV-infected patients under immunological and virological stable conditions]

Pedrol E, Martín T, del Pozo MA, Flores J, Sanz J, Cartón JA, Jusdado JJ, Arazo P, Ribera E, Deig E; Grupo de Estudio de Evaluación del uso de Análogos de Nucleósidos.

Med Clin (Barc). 2007 Sep 22;129(10):361-5. Spanish. PMID: 17915129 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study.

Peñaranda M, Falco V, Payeras A, Jordano Q, Curran A, Pareja A, Samperiz G, Dalmau D, Ribera E, Riera M.

Clin Infect Dis. 2007 Oct 1;45(7):e82-7. Epub 2007 Aug 21.PMID: 17806042 [PubMed - indexed for MEDLINE]Related articles

Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.

Molina I, Falcó V, Crespo M, Riera C, Ribera E, Curran A, Carrio J, Diaz M, Villar del Saz S, Fisa R, López-Chejade P, Ocaña I, Pahissa A.

J Antimicrob Chemother. 2007 Oct;60(4):837-42. Epub 2007 Aug 7.PMID: 17684055 [PubMed - indexed for MEDLINE]Related articlesFree article

Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients.

Crespo M, Sauleda S, Esteban JI, Juarez A, Ribera E, Andreu AL, Falco V, Quer J, Ocaña I, Ruiz I, Buti M, Pahissa A, Esteban R, Guardia J.

J Viral Hepat. 2007 Apr;14(4):228-38.PMID: 17381714 [PubMed - indexed for MEDLINE]Related articles

Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment.

Hill A, Ruxrungtham K, Hanvanich M, Katlama C, Wolf E, Soriano V, Milinkovic A, Gatell J, Ribera E.

Expert Opin Pharmacother. 2007 Apr;8(5):679-88. Review.PMID: 17376022 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.

Ribera E, Azuaje C, Lopez RM, Domingo P, Curran A, Feijoo M, Pou L, Sánchez P, Sambeat MA, Colomer J, Lopez-Colomes JL, Crespo M, Falcó V, Ocaña I, Pahissa A.

J Antimicrob Chemother. 2007 Apr;59(4):690-7. Epub 2007 Feb 16.PMID: 17307771 [PubMed - indexed for MEDLINE]Related articlesFree article

Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.

Castells L, Esteban JI, Bilbao I, Vargas V, Allende H, Ribera E, Piron M, Sauleda S, Len O, Pahissa A, Esteban R, Guardia J, Margarit C.

Antivir Ther. 2006;11(8):1061-70.PMID: 17302376 [PubMed - indexed for MEDLINE]Related articles

Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients.

Crespo M, Esteban JI, Ribera E, Falco V, Sauleda S, Buti M, Esteban R, Guardia J, Ocaña I, Pahissa A.

AIDS. 2007 Feb 19;21(4):477-81.PMID: 17301566 [PubMed - indexed for MEDLINE]Related articles

Liver transplantation in HIV-HCV coinfected patients: a case-control study.

Castells L, Escartín A, Bilbao I, Len O, Allende H, Vargas V, Ribera E, Lázaro JL, Bueno J, Balsells J, Esteban R, Pahissa A, Margarit C.

Transplantation. 2007 Feb 15;83(3):354-8.PMID: 17297413 [PubMed - indexed for MEDLINE]Related articles

[Spanish recommendations for proper use of enfuvirtide]

Ribera E, Moreno S, Viciana P, Echevarría S, Flores J, Francés A, Gómez-Sirvent JL, González J, Hernández-Quero J, Lozano F, Mallolas J, Muñoz A, Ocampo A, Portilla J, Pulido F, Rivero A, Santos J, Soriano V, Antela A, Arazo P, Arribas JR, Cervantes M, Domingo P.

Enferm Infecc Microbiol Clin. 2007 Feb;25(2):131-42. Review. Spanish. PMID: 17288910 [PubMed - indexed for MEDLINE]Related articlesFree article

[Prognostic value of circumferential resection margin involvement in patients with locally-advanced rectal cancer]

Alecha JS, Ribera EB, Dorronsoro MG, Ripa CZ, Cabezón JH, Tricas JM.

Cir Esp. 2007 Jan;81(1):18-22. Spanish. PMID: 17263953 [PubMed - indexed for MEDLINE]Related articlesFree article

Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients.

Martínez E, Arnaiz JA, Podzamczer D, Dalmau D, Ribera E, Domingo P, Knobel H, Leyes M, Pedrol E, Force L, de Lazzari E, Gatell JM.

AIDS. 2007 Jan 30;21(3):367-9.PMID: 17255745 [PubMed - indexed for MEDLINE]Related articles

Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study.

Podzamczer D, Ferrer E, Sanchez P, Gatell JM, Crespo M, Fisac C, Lonca M, Sanz J, Niubo J, Veloso S, Llibre JM, Barrufet P, Ribas MA, Merino E, Ribera E, Martínez-Lacasa J, Alonso C, Aranda M, Pulido F, Berenguer J, Delegido A, Pedreira JD, Lérida A, Rubio R, del Río L; ABCDE (Abacavir vs. d4T (stavudine) plus efavirenz) Study Team.

J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):139-47.PMID: 17106274 [PubMed - indexed for MEDLINE]Related articles

Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patients.

de Mendoza C, Valer L, Ribera E, Barreiro P, Martín-Carbonero L, Ramirez G, Soriano V.

HIV Clin Trials. 2006 Jul-Aug;7(4):163-71.PMID: 17065028 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.

Cabrera C, Marfil S, García E, Martinez-Picado J, Bonjoch A, Bofill M, Moreno S, Ribera E, Domingo P, Clotet B, Ruiz L.

AIDS. 2006 Oct 24;20(16):2075-80.PMID: 17053353 [PubMed - indexed for MEDLINE]Related articles

Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.

Miro JM, Lopez JC, Podzamczer D, Peña JM, Alberdi JC, Martínez E, Domingo P, Cosin J, Claramonte X, Arribas JR, Santín M, Ribera E; GESIDA 04/98 Study Group.

Clin Infect Dis. 2006 Jul 1;43(1):79-89. Epub 2006 May 31. Erratum in: Clin Infect Dis. 2006 Sep 1;43(5):671. PMID: 16758422 [PubMed - indexed for MEDLINE]Related articles

[Tuberculous meningitis: a comparative study in relation to concurrent human immunodeficiency virus infection]

Azuaje C, Fernández Hidalgo N, Almirante B, Martín-Casabona N, Ribera E, Díaz M, Prats G, Pahissa A.

Enferm Infecc Microbiol Clin. 2006 Apr;24(4):245-50. Spanish. PMID: 16725084 [PubMed - indexed for MEDLINE]Related articlesFree article

Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen.

Ribera E, Azuaje C, Lopez RM, Diaz M, Feijoo M, Pou L, Crespo M, Curran A, Ocaña I, Pahissa A.

AIDS. 2006 May 12;20(8):1131-9.PMID: 16691064 [PubMed - indexed for MEDLINE]Related articles

Bridge to transplantation with the MicroMed DeBakey ventricular assist device axial pump: a single centre report.

Bruschi G, Ribera E, Lanfranconi M, Russo C, Colombo T, Garatti A, Oliva F, Milazzo F, Frigerio M, Vitali E.

J Cardiovasc Med (Hagerstown). 2006 Feb;7(2):114-8.PMID: 16645370 [PubMed - indexed for MEDLINE]Related articles

Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.

Bonjoch A, Paredes R, Domingo P, Cervantes M, Pedrol E, Ribera E, Force L, Llibre JM, Vilaró J, Dalmau D, Cucurull J, Mascaró J, Masabeu A, Pérez-Alvarez N, Puig J, Cinquegrana D, Clotet B.

AIDS Res Hum Retroviruses. 2006 Apr;22(4):321-9.PMID: 16623634 [PubMed - indexed for MEDLINE]Related articles

Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study.

Falcó V, Jordano Q, Cruz MJ, Len O, Ribera E, Campins M, Crespo M, Ocaña I, Rodrigo MJ, Pahissa A.

Vaccine. 2006 Mar 24;24(14):2567-74. Epub 2005 Dec 27.PMID: 16423429 [PubMed - indexed for MEDLINE]Related articles

Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?

Ribera E, López-Cortés LF, Soriano V, Casado JL, Mallolas J.

Enferm Infecc Microbiol Clin. 2005 Jul;23(Supl.2):55-67.PMID: 16373004 [PubMed - as supplied by publisher]Related articlesFree article

[Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they applied to the current situation?]

Ribera E, López-Cortés LF, Soriano V, Casado JL, Mallolas J.

Enferm Infecc Microbiol Clin. 2005 Jul;23 Suppl 2:41-54. Spanish. PMID: 16373003 [PubMed - in process]Related articlesFree article